SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
Date of Report (Date of earliest event reported): November 6, 2003 |
|
|
|
Anika Therapeutics, Inc. |
|
(Exact Name of Registrant as Specified in Its Charter) |
|
Massachusetts |
|
000-21326 |
|
04-3145961 |
|
(State or
Other Jurisdiction of |
|
(Commission
file |
|
(I.R.S. Employer Identification No.) |
|
|
|
|
|
|
|
160 New Boston Street, Woburn, Massachusetts |
|
01801 |
||
|
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: (781) 932-6616 |
ITEM 7: FINANCIAL STATEMTENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) Exhibits
Exhibit 99.1 — Press Release of Anika Therapeutics, Inc. dated November 6, 2003.
ITEM 12: RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
On November 6, 2003, Anika Therapeutics, Inc. issued a press release (“Press Release”) announcing its financial results for the third quarter of 2003. A copy of the Press Release is attached as Exhibit 99.1 to this Current Report and is incorporated herein by reference.
Such information, including the exhibits attached hereto, shall not be deemed filed for any purpose, including for purposes of, Section 18 of the Securities and Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 of the Exchange Act, regardless of any general incorporation language in such filing.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized in Woburn, Massachusetts on November 7, 2003.
|
|
ANIKA THERAPEUTICS, INC. |
||
|
|
|
||
|
November 7, 2003 |
By: |
/s/ Charles H. Sherwood |
|
|
|
|
Charles H. Sherwood, Ph.D. |
|
3
Exhibit Index
|
Exhibit No. |
|
Description |
|
99.1 |
|
Press Release of Anika Therapeutics, Inc. dated November 6, 2003 |
4